Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Metadata
Title
A moxonidine trial has been stopped by Lilly and Solvay because of a higher mortality rate
Publication date
01-04-1999
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/1999
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-199907450-00004

Other articles of this Issue 1/1999

Reactions Weekly 1/1999 Go to the issue

Case report

Quinapril

Case report

Dipyrone

Case reports

Nefazodone

Volunteers

Paracetamol administration did not significantly change the anticoagulant response to warfarin

Case report

Dopamine

Case report

Prednisone withdrawal